Discharge From Treatment for Drug Use

Policy Statement

Number 3

May 1994

It must be emphasized that methadone maintenance treatment is a medical

treatment for narcotic addiction. Recent research has found that abstinent

former heroin users have irregularities within their immune and endocrine

systems. However, these irregularities are normalized with methadone

maintenance. This further underscores that methadone maintenance is a medical

treatment for a medical condition that has sociological and psychological

aspects, as do many medical conditions, i.e. heart disease. No other treatment for

opiate addiction as is successful as methadone maintenance, resulting in a 92%

reduction in heroin use when treatment is appropriately done. No other treatment

for heroin addiction can boast such a success rate, and in fact very few other

medical treatments have as high a success rate as methadone maintenance.

Programs who have high rates of illicit opioid use are, put simply, “not

providing proper treatment.” Discharging patients for heroin use is

unethical and usually programs which use such tactics are not providing adequate

dosage or are using the medication as a tool to manipulate the patient’s

behavior. Such procedures would be considered unethical in every other realm of

medicine, but because drug use has been perceived as a behavioral problem,

discharging patients for drug use has been tolerated in methadone treatment.

Imagine how this feels to the patient in treatment. What if you were

diagnosed with cancer and went for the usual radiation treatments. You followed

everything the doctor told you to do, but in the end the cancer was still

growing. Now apply this to methadone treatment: you would be discharged because

you did not respond to treatment. If you had cancer would you not want the

doctor to try something else, like chemotherapy and if that failed perhaps some

new experimental treatment? You would want the doctor to try everything to save

your life. The same is true for the methadone patient, if 70 mg doesn’t work,

then perhaps 80 or 90 or 200 mg will work. For the cancer patient perhaps two

radiation treatments will work. But imagine the doctor blaming the cancer

patient for not responding to treatment and then discharging them. “If only

you had tried harder!” This happens to methadone patients every day, they

are blamed for the failures of their programs.

Not only does discharging methadone patients from treatment do a terrible

disservice to the patient, but also to the community. Think of the repercussions

when a patient is discharged. It is inevitable that they will relapse within a

short time and considering the threat of HIV, strain resistant TB, hepatitis and

endocarditis the effects that the discharge will have on the family of the

patient is tremendous. The patient will no longer be able to support their

family because they will be thrown into a state of “drug craving.” The

crime that one patient will have to commit to maintain their drug use has been

estimated to cost society from $150,000 to over $300,000 a year. And if this

former patient is arrested, which is very likely, then they will be a ward of

the state costing between $30,000 to $60,000 a year. And should this former

patient become infected with HIV the cost can be as high as $300,000 a year, and

as people with AIDS are living longer the costs are rising dramatically.

Now I ask you, which is better for the person, the community and the state? A

methadone patient receiving adequate treatment who supports their family, pays

their taxes, pays for their treatment and is a productive member of the

community, or a heroin addict who will cost the community money that could well

be spent on better purposes?

A Comment on Discharging Patients for Using Cocaine

Many programs have adopted the policy of discharging methadone patients for

using cocaine. Presently there is no treatment for cocaine use, except

hospitalization and counseling and hoping that this time something works.

However, NAMA believes that it is unethical to discharge patients and thus

refuse to them treatment for their heroin addiction because they have developed

an ancillary problem. In normal medical practice a patient with diabetes who did

not follow medical advise now developed heart disease because of this would not

be refused their insulin. Neither should a medication that works for heroin

addiction be refused because of another drug problem.

There are programs that discharge for marijuana use. This simply does not

make sense nor does it serve the community or the patient and their family.

Marijuana is used by a large number of Americans and is associated with neither

the high crime rates nor the significant medical consequences resultant from

abuse of other illicit drugs or alcohol. Furthermore, many AIDS patients use

marijuana on medical advice as a means of countering the “wasting

syndrome”. Discharging methadone patients for using marijuana results in an

untreated heroin addict that will cost the community in crime and money.

[Download PDF] 

[Next Policy Statement]

[Index Policy Statements]

Similar Posts

  • Invitational Conference on Drug User Activism

    Admin 02/11/2023

    International Drug User Day 2003, October 31st/November 1st Copenhagen, Denmark Early Morning Smiles Eliot Albert (Methadone Alliance on loan to BF) finishes up some work in preparation for his workshop. Final Check Eliot Albert (Methadone Alliance) takes a final walk through the kitchen and reception area to make sure every is ready for the arrival…

  • Reception

    Admin 08/15/2021

    Welcome to The President’s Office and to the National Alliance for Medication Assisted Recovery or NAMA Recovery. NAMA Recovery has gone through some significant changes in the past few years. We are proud of the MARS Project the first project of its kind that provides recovery services to patients receiving Medication Assisted Treatment (MAT). As…

  • WI NAMA

    Admin 03/26/2023

    Wisconsin Chapter of the National Alliance of Methadone Advocates 3237 North Dousman Milwaukee, WI 53212 President Greg Keller   Mission Statement WI NAMA believes in the same Mission and goals as NAMA. Since its beginning over 25 years ago, methadone maintenance has been the most popular treatment for narcotic addiction. Many times over the years…

  • Category: Lane Holden Award

    Admin 07/18/2022

    Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award! May 1, 2022 Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive Director of Man Alive and later served as Vice President…

  • |

    National Alliance of Methadone Advocates Inc 435 Second Avenue New York, NY 10010      

    Admin 09/21/2021

    Membership Application Name:   _______________________________________________________   Mr. ___  Ms. ___  Dr. ___ Organization:  __________________________________________________________________________ Title:  _____________________________________________  Degree(s):  ________________________ Address:  _____________________________________________________________________________ Address:  _____________________________________________________________________________ City:   __________________________________   State:   ____________   Postal Code:   _____________ Email:  ______________________________________  Country:   ________________________________ Home Phone: (____)___________________________   Work Phone:  (____)_______________________ Alternate Phone:  (____)________________________   Fax:  (____)______________________________ If you have email may we send you bulletin alerts electronically. (This will get bulletin alerts to you quicker than usual mail)   Yes  _____   No _____ Types of Membership $_______ Individual Membership   Dues: $25 a…

  • Registering for Training and Certification

    Admin 04/25/2022

    You have to register for the Certified Methadone Advocate Training course through NAMA. The training course is one day. The first training will be at the AATOD Conference in Washington on Saturday April 12, 2003. The cost of course is $100 and includes 2003 membership in NAMA. Everyone who pre-registers and completes the requirements will…